PODCAST Dr. Keith Heinzerling interview: psilocybin clinical trials
psychedelics for creativity
what it's like sitting with a patient that's on a psychedelic trip
why TRIP chose psilocybin (active ingredient in magic mushrooms) for their clinical trial
surprises as he watches patients experience psychedelics
viability of "remote trip monitoring" for psychedelics
what Dr. Heinzerling would do if he was the "U.S. drug czar"
He is a physician board certified in Internal Medicine and Addiction Medicine. He is the Director of the Treatment & Research in Psychedelics (TRIP) Program at the Pacific Neuroscience Institute in Santa Monica. He is a graduate of the psychedelic therapist training program at the Center for Psychedelic Therapies and Research at CIIS in San Francisco.
Find Dr. Heinzerling at https://pacifictrip.org/